Net Cash Provided by (Used in) Operating Activities |
-373K |
USD |
-153% |
Q2 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
391K |
USD |
|
Q2 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q2 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
7M |
shares |
0% |
Q3 2024 |
Q2 2025 |
Common Stock, Shares, Issued |
3.26M |
shares |
0% |
Q3 2024 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0.1 |
USD/shares |
0% |
Q3 2024 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
242K |
USD |
-32.1% |
Q3 2024 |
Q2 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
17.9K |
USD |
+32.8% |
Q2 2024 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
138K |
USD |
+37.8% |
Q1 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
2.59M |
USD |
-5.11% |
Q1 2024 |
FY 2024 |
Operating Lease, Liability |
1.22M |
USD |
-14.4% |
Q3 2024 |
Q2 2025 |
Payments to Acquire Property, Plant, and Equipment |
0 |
USD |
-100% |
Q2 2024 |
Q1 2025 |
Lessee, Operating Lease, Liability, to be Paid |
1.34M |
USD |
-16% |
Q3 2024 |
Q2 2025 |
Operating Lease, Liability, Current |
206K |
USD |
0% |
Q3 2024 |
Q2 2025 |
Lessee, Operating Lease, Liability, to be Paid, Year Two |
268K |
USD |
+5.07% |
Q3 2024 |
Q2 2025 |
Lessee, Operating Lease, Liability, to be Paid, Year One |
127K |
USD |
+0% |
Q3 2024 |
Q2 2025 |
Deferred Income Tax Expense (Benefit) |
11.2K |
USD |
-86.1% |
Q2 2024 |
Q1 2025 |
Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
121K |
USD |
-28.7% |
Q3 2024 |
Q2 2025 |
Lessee, Operating Lease, Liability, to be Paid, Year Three |
277K |
USD |
+3.45% |
Q3 2024 |
Q2 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
1.23M |
USD |
+118% |
Q1 2024 |
FY 2024 |
Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Q1 2024 |
FY 2024 |
Lessee, Operating Lease, Liability, to be Paid, Year Four |
277K |
USD |
0% |
Q3 2024 |
Q2 2025 |
Additional Paid in Capital |
6.19M |
USD |
-5.64% |
Q3 2024 |
Q2 2025 |
Depreciation, Depletion and Amortization |
9.03K |
USD |
-26.4% |
Q3 2024 |
Q2 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
2.45M |
USD |
-6.75% |
Q1 2024 |
FY 2024 |
Share-based Payment Arrangement, Expense |
1.94K |
USD |
-0.05% |
Q3 2024 |
Q2 2025 |
Interest Expense |
0 |
USD |
-100% |
Q1 2022 |
FY 2023 |
Preferred Stock, Par or Stated Value Per Share |
0.1 |
USD/shares |
0% |
Q1 2024 |
FY 2024 |